Filter Results:
(2,576)
Show Results For
- All HBS Web
(2,576)
- People (4)
- News (589)
- Research (1,508)
- Events (14)
- Multimedia (40)
- Faculty Publications (988)
Show Results For
- All HBS Web
(2,576)
- People (4)
- News (589)
- Research (1,508)
- Events (14)
- Multimedia (40)
- Faculty Publications (988)
- 1988
- Chapter
Evaluation of Government Financial Incentives to Large Scale Energy Projects: A Contingent Claims Approach
By: Carliss Y. Baldwin and Scott P. Mason
- 23 Sep 2017
- Working Paper Summaries
Nowcasting the Local Economy: Using Yelp Data to Measure Economic Activity at Scale
- August 2019
- Supplement
Rand Fishkin at Moz (C)
Supplements the (A) case. View Details
Keywords: Startups; Scaling; Entrepreneurship; Failure; Business Startups; Diversification; Growth Management
Eisenmann, Thomas R. "Rand Fishkin at Moz (C)." Harvard Business School Supplement 820-004, August 2019.
- Sep 2013
- Case
IBM and the Reinvention of High School (B): Replicating & Scaling P-TECH and Partners
This case explores the challenges and complications of replicating P-TECH. View Details
- Article
Scale and Scope in Drug Development: Unpacking the Advantages of Size in Pharmaceutical Research
By: Rebecca Henderson and Iain Cockburn
Henderson, Rebecca, and Iain Cockburn. "Scale and Scope in Drug Development: Unpacking the Advantages of Size in Pharmaceutical Research." Journal of Health Economics 20, no. 6 (November 2001).
- 08 Apr 2021
- Podcast
Bringing Scale Capital to Climate Game-Changers: David Crane, Climate Real Impact Solutions SPAC
David Crane tried to lead the NRG utility to transition from fossil fuel energy sources, but was ousted in 2015. He shares his lessons learned, reflects on what’s changed since then, and describes his newest venture raising funds for a climate-tech SPAC. View Details
- Article
Scale and Scope in Drug Development: Unpacking the Advantages of Size in Pharmaceutical Research
By: Rebecca M. Henderson and Iain Cockburn
Henderson, Rebecca M., and Iain Cockburn. "Scale and Scope in Drug Development: Unpacking the Advantages of Size in Pharmaceutical Research." Journal of Health Economics 20, no. 6 (November 2001): 32–59.
- August 2019
- Supplement
Rand Fishkin at Moz (B)
Supplements the (A) case. View Details
Keywords: Startups; Scaling; Entrepreneurship; Failure; Business Startups; Diversification; Growth Management
Eisenmann, Thomas R. "Rand Fishkin at Moz (B)." Harvard Business School Supplement 820-003, August 2019.
- October 2013
- Teaching Note
Teaching Note IBM and the Reinvention of High School (B): Replicating & Scaling P-TECH and Partners
By: Rosabeth M. Kanter and Ai-Ling Jamila Malone
- December 2012 (Revised September 2022)
- Case
BabbaCo
By: Jeffrey J. Bussgang and Gaurav Jain
Having just raised a Series B financing, the case protagonist is faced with a tough decision: should she "step on the gas" and scale the customer base, or continue focusing on fine-tuning the product and business model. The case describes the various marketing channels... View Details
Keywords: Subscription; Marketing; Scaling; Product-market Fit; Online Marketing; Customers; Decisions; Expansion; Marketing Channels; Business Startups; Growth and Development Strategy; Digital Marketing; Marketing Strategy
Bussgang, Jeffrey J., and Gaurav Jain. "BabbaCo." Harvard Business School Case 813-107, December 2012. (Revised September 2022.)
- January 2010
- Teaching Note
Youth Villages: The challenges of scaling a nonprofit with government as the primary funding source (TN)
Teaching Note for [309007]. View Details
- July 2019 (Revised May 2020)
- Supplement
Piramal e-Swasthya (C): A New Name, Bigger Scope, and Public-Private Partnerships
By: Rosabeth Moss Kanter and Joyce J. Kim
In 2010, Anand Piramal acquired the Health Management Research Institute (HMRI), a healthcare venture, and merged it with his original digital healthcare startup Piramal e-Swasthya (PeS), so that PeS became Piramal Swasthya. After acquiring HMRI, Piramal Swasthya... View Details
Keywords: Entrepreneur; Healthcare; Innovation; Emerging Economies; Scaling; Social Enterprise; Entrepreneurship; Health Care and Treatment; Innovation and Management; Emerging Markets; Growth and Development; Organizational Change and Adaptation; Partners and Partnerships; India
Kanter, Rosabeth Moss, and Joyce J. Kim. "Piramal e-Swasthya (C): A New Name, Bigger Scope, and Public-Private Partnerships." Harvard Business School Supplement 320-012, July 2019. (Revised May 2020.)
- October 2018 (Revised May 2019)
- Case
Khan Academy 2018
By: William Sahlman and Nicole Tempest Keller
Founded in 2008, Khan Academy was a global educational nonprofit with a mission to provide a free, world-class education for anyone anywhere in the world. By 2018, the organization had expanded into numerous content areas, product areas, and geographic markets.... View Details
Keywords: Entrepreneur; Sustainability; Scaling; Social Entrepreneurship; Nonprofit Organizations; Strategy; Education; Entrepreneurship; Teaching; Education Industry; California
Sahlman, William, and Nicole Tempest Keller. "Khan Academy 2018." Harvard Business School Case 819-064, October 2018. (Revised May 2019.)
- July 2025
- Article
Extraverts Reap Greater Social Rewards from Passion Because They Express Passion More Frequently and More Diversely
By: Kai Krautter, Anabel Büchner and Jon M. Jachimowicz
Passion is stereotypically expressed through animated facial expressions, energetic body movements, varied tone, and pitch—and met with interpersonal benefits. However, these capture only a subset of passion expressions that are more common for extraverts. Indeed, in... View Details
Keywords: Passion; Personality; Extraversion; Scale Development; Perception; Personal Characteristics
Krautter, Kai, Anabel Büchner, and Jon M. Jachimowicz. "Extraverts Reap Greater Social Rewards from Passion Because They Express Passion More Frequently and More Diversely." Personality and Social Psychology Bulletin 51, no. 7 (July 2025): 1159–1172.
- 2016
- Chapter
Evaluating the Effects of Large Scale Health Interventions in Developing Countries: The Zambian Malaria Initiative
By: Nava Ashraf, Gunther Fink and David N. Weil
Since 2003, Zambia has been engaged in a large-scale, centrally coordinated national anti-Malaria campaign, which has become a model in sub-Saharan Africa. This paper aims at quantifying the individual and macro-level benefits of this campaign, which involved mass... View Details
Ashraf, Nava, Gunther Fink, and David N. Weil. "Evaluating the Effects of Large Scale Health Interventions in Developing Countries: The Zambian Malaria Initiative." Chap. 1 in African Successes, Volume 2: Human Capital, edited by Sebastian Edwards, Simon Johnson, and David N. Weil. University of Chicago Press, 2016.